BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22627184)

  • 21. Modeling the implementation of population-level isoniazid preventive therapy for tuberculosis control in a high HIV-prevalence setting.
    Rhines AS; Feldman MW; Bendavid E
    AIDS; 2018 Sep; 32(15):2129-2140. PubMed ID: 30096067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic.
    Rangaka MX; Wilkinson RJ; Glynn JR; Boulle A; van Cutsem G; Goliath R; Mathee S; Maartens G
    Clin Infect Dis; 2012 Dec; 55(12):1698-706. PubMed ID: 22955441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS.
    Gutierrez EB; Gomes V; Picone CM; Suga H; Atomiya AN
    HIV Med; 2009 Oct; 10(9):564-72. PubMed ID: 19785665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding.
    Hanifa Y; Fielding KL; Charalambous S; Variava E; Luke B; Churchyard GJ; Grant AD
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1252-9. PubMed ID: 22794030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
    Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC
    PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized ART initiation in a large urban HIV clinic in Uganda.
    Hermans SM; Castelnuovo B; Katabira C; Mbidde P; Lange JM; Hoepelman AI; Coutinho A; Manabe YC
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):e29-35. PubMed ID: 22395671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
    Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
    BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of routine abdominal ultrasonography in intensified tuberculosis case finding algorithms at HIV clinics in high TB burden settings.
    Spalgais S; Agarwal U; Sarin R; Chauhan D; Yadav A; Jaiswal A
    BMC Infect Dis; 2017 May; 17(1):351. PubMed ID: 28521786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
    Kiwuwa-Muyingo S; Kikaire B; Mambule I; Musana H; Musoro G; Gilks CF; Levin JB; Walker AS
    AIDS; 2014 Nov; 28(17):2579-88. PubMed ID: 25574960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
    Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
    PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
    Nakiyingi L; Ssengooba W; Nakanjako D; Armstrong D; Holshouser M; Kirenga BJ; Shah M; Mayanja-Kizza H; Joloba ML; Ellner JJ; Dorman SE; Manabe YC
    BMC Infect Dis; 2015 Feb; 15():62. PubMed ID: 25888317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.
    Auld AF; Kerkhoff AD; Hanifa Y; Wood R; Charalambous S; Liu Y; Agizew T; Mathoma A; Boyd R; Date A; Shiraishi RW; Bicego G; Mathebula-Modongo U; Alexander H; Serumola C; Rankgoane-Pono G; Pono P; Finlay A; Shepherd JC; Ellerbrock TV; Grant AD; Fielding K
    PLoS Med; 2021 Sep; 18(9):e1003739. PubMed ID: 34491987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial.
    Maskew M; Brennan AT; Fox MP; Vezi L; Venter WDF; Ehrenkranz P; Rosen S
    PLoS Med; 2020 Aug; 17(8):e1003226. PubMed ID: 32853271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active tuberculosis case-finding among pregnant women presenting to antenatal clinics in Soweto, South Africa.
    Gounder CR; Wada NI; Kensler C; Violari A; McIntyre J; Chaisson RE; Martinson NA
    J Acquir Immune Defic Syndr; 2011 Aug; 57(4):e77-84. PubMed ID: 21436710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
    Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A;
    Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults.
    Moh R; Badjé A; N'takpé JB; Kouamé GM; Gabillard D; Ouassa T; Ouattara E; Le Carrou J; Bohoussou F; Messou E; Eholié S; Anglaret X; Danel C
    Int J Tuberc Lung Dis; 2017 Dec; 21(12):1237-1244. PubMed ID: 29297443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    BMC Med; 2013 Oct; 11():231. PubMed ID: 24168211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High rates of tuberculosis in patients accessing HAART in rural South Africa.
    Naidoo K; Karim QA; Bhushan A; Naidoo K; Yende-Zuma N; McHunu PK; Frohlich J; Karim F; Upfold M; Kocheleff P; Abdool Karim SS
    J Acquir Immune Defic Syndr; 2014 Apr; 65(4):438-46. PubMed ID: 24256629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
    Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
    BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.